Wall Street finishes higher following better than expected jobs data
Market sentiment picked up on Thursday, allowing the main indices in New York to stage a rebound
4:16pm: Nasdaq cooled in the afternoon but still closed in the green
The blue chip index closed up 434 points, 1.3%, at 34,021. The Nasdaq improved 93 points, 0.7%, to 13,125, and the S&P 500 gained 49 points, 1.2%, to 4,123.
Apple Inc (NASDAQ:AAPL) shares gained 1.8% to $124.97, which helped the Nasdaw finish in the green, but losses from the likes of Tesla Inc (NASDAQ:TSLA) pulled the index down from its early morning high, including a brief dip into the red. Shares of the electric carmaker declined more than 3% to $571.69.
FTSE 100 closes ahead as US jobs miss boosts shares
The UK index of top shares closed up over 53 points at 7,129. The midcap FTSE 250 was also higher, adding almost 284 points at 22,775
FTSE 100 closes up at 7,129
Flight prices to Portugal jump 10-fold
US adds 266,000 jobs instead of 1mln
5.10pm: FTSE closes ahead
FTSE 100 closed Friday ahead as Wall Street headed north too as the big miss on the US monthly jobs number convinced traders the US central bank wouldn t change direction any time soon.
The UK index of top shares closed up over 53 points at 7,129. The midcap FTSE 250 was also higher, adding almost 284 points at 22,775.
Dow and S&P 500 soar to a record close despite April jobs miss
Employers added just 266,000 jobs last month, while unemployment rose to 6.1% Reuters had predicted that April US non-farm payrolls (NFP) would increase by 978,000 jobs after rising by 916,000 in March
4:05pm: Missed expectations on job data doesn t slow Wall Street
The Dow closed Friday up 228 points, 0.7%, at 34,776, a record finish. The S&P 500 gained 31 points, 0.7%, to 4,232, also a record, and the Nasdaq improved 119 points, 0.9%, to 13,752.
Investors had to grapple with a major jobs miss as employers added just 266,000 jobs last month, well below Street expectations of roughly 1 million, while unemployment rose to 6.1%.
XPhyto establishes a proof-of-concept station for its 25-minute point-of-care COVID-19 PCR test in Germany
The company said the pilot project includes “point-of-care sample collection, PCR processing and final testing of workflow logistics” The project is in co-operation with a German pharmacy, Spitzweg Apotheke which is currently running a coronavirus test center
XPhyto Therapeutics Corp (CSE:XPHY) (OTCQB:XPHYF)( FRA:4XT) revealed that it has kicked off a pilot project with its rapid coronavirus (COVID-19) PCR test in a point-of-care (POC) setting in Germany.
The Vancouver-based bioscience accelerator’s Covid-ID Lab test was recently approved in Europe and offers the accuracy of a PCR test in 25 minutes flat. During the pilot, the validated workflows for the test including the mobile collection and processing of patient samples will be optimized, said the company.
NA Proactive news snapshot: KWESST Micro Systems, Sassy Resources, Power REIT, Delta 9 Cannabis UPDATE …
A glance at some of the day s highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive
KWESST Micro Systems Inc (CVE:KWE) (OTCQB:KWEMF) announced plans to hold an investor update call at 2 pm ET on Tuesday, May 11. Executive Chairman David Luxton will describe the significance of the company s acquisition of Low Energy Cartridge (LEC) systems and the go-to-market strategy for the LEC, the world s first cartridge based non-lethal weapon system. Interested parties can email questions to investors@kwesst.com prior to or during the meeting. To dial in, call 647-374-4685 in Canada or 929-205-6099 in the US. One priority for KWESST is to begin the commercialization of the LEC system with an accelerated plan in response to market interest and high growth across all segments of the non-lethal market. In this market